Susquehanna International Group, LLP Fulcrum Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 99,490 shares of FULC stock, worth $945,155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
99,490
Previous 64,840
53.44%
Holding current value
$945,155
Previous $186,000
267.74%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding FULC
# of Institutions
130Shares Held
55.5MCall Options Held
886KPut Options Held
93.3K-
Ra Capital Management, L.P. Boston, MA10.2MShares$97.2 Million1.54% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$49.9 Million7.36% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.08MShares$48.3 Million1.2% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$45.6 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.59MShares$43.6 Million0.06% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $494M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...